Extracellular Vesicles from MSC Modulate the Immune Response to Renal Allografts in a MHC Disparate Rat Model

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Koch, M ^a   Lemke, A ^a   Lange, C ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; CD3 ANTIGEN; CD4 ANTIGEN; CREATININE; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL TRANSPLANTATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EXOSOME; IMMUNOMODULATION; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY DYSFUNCTION; LEUKOCYTE; LEUKOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MALE; MESENCHYMAL STROMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY T LYMPHOCYTE;

ANIMALIA; RATTUS;

EID: 84940399026     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/486141     Document Type: Article

References (32)

1. S. Aggarwal and M. F. Pittenger, "Human mesenchymal stem cells modulate allogeneic immune cell responses," Blood, vol. 105, no. 4, pp. 1815-1822, 2005.
2. S. E. Haynesworth, M. A. Baber, and A. I. Caplan, "Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1," Journal of Cellular Physiology, vol. 166, no. 3, pp. 585-592, 1996.
3. O. N. Koç and H. M. Lazarus, "Mesenchymal stem cells: heading into the clinic," Bone Marrow Transplantation, vol. 27, no. 3, pp. 235-239, 2001.
4. A. Uccelli, L. Moretta, and V. Pistoia, "Mesenchymal stem cells in health and disease," Nature Reviews Immunology, vol. 8, no. 9, pp. 726-736, 2008.
5. A. J. Nauta andW. E. Fibbe, "Immunomodulatory properties of mesenchymal stromal cells," Blood, vol. 110, no. 10, pp. 3499-3506, 2007.
6. K. Le Blanc, H. Samuelsson, B. Gustafsson et al. , "Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells," Leukemia, vol. 21, no. 8, pp. 1733-1738, 2007.
7. A. Uccelli, L. Moretta, and V. Pistoia, "Immunoregulatory function of mesenchymal stem cells," European Journal of Immunology, vol. 36, no. 10, pp. 2566-2573, 2006.
8. M. Koch, A. Lehnhardt, X. Hu et al. , "IsogeneicMSCapplication in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival," Transplant Immunology, vol. 29, no. 1-4, pp. 43-50, 2013.
9. M. Seifert, M. Stolk, D. Polenz, and H.-D. Volk, "Detrimental effects of ratmesenchymal stromal cell pre-treatment in amodel of acute kidney rejection," Frontiers in Immunology, vol. 3, article 202, 2012.
10. J. Haarer, C. L. Johnson, Y. Soeder, andM. H. Dahlke, "Caveats of mesenchymal stem cell therapy in solid organ transplantation," Transplant International, vol. 28, no. 1, pp. 1-9, 2015.
11. S. J. Gould and G. Raposo, "Aswe wait: copingwith an imperfect nomenclature for extracellular vesicles," Journal of Extracellular Vesicles, vol. 2, Article ID20389, 2013.
12. G. Raposo andW. Stoorvogel, "Extracellular vesicles: exosomes, microvesicles, and friends," Journal of Cell Biology, vol. 200, no. 4, pp. 373-383, 2013.
13. C. Théry, "Exosomes: secreted vesicles and intercellular communications," F1000 Biology Reports, vol. 3, no. 1, article 15, 2011.
14. K. W. Witwer, E. I. Buzás, L. T. Bemis et al. , "Standardization of sample collection, isolation and analysis methods in extracellular vesicle research," Journal of Extracellular Vesicles, vol. 2, 2013.
15. C. Akyurekli, Y. Le, R. B. Richardson, D. Fergusson, J. Tay, and D. S. Allan, "A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles," Stem Cell Reviews and Reports, vol. 11, no. 1, pp. 150-160, 2015.
16. B. György, M. E. Hung, X. O. Breakefield, and J. N. Leonard, "Therapeutic applications of extracellular vesicles: clinical promise and open questions," Annual Review of Pharmacology and Toxicology, vol. 55, pp. 439-464, 2015.
17. D. C. de Almeida, C. Donizetti-Oliveira, P. Barbosa-Costa, C. S. Origassa, and N. O. Camara, "In search of mechanisms associated with mesenchymal stem cell-based therapies for acute kidney injury," The Clinical Biochemist Reviews, vol. 34, pp. 131-144, 2013.
18. X. Zou, G. Zhang, Z. Cheng et al. , "Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1," Stem Cell Research & Therapy, vol. 5, article 40, 2014.
19. C. Lange, F. Tögel, H. Ittrich et al. , "Administered mesenchymal stem cells enhance recovery from ischemia/reperfusioninduced acute renal failure in rats," Kidney International, vol. 68, no. 4, pp. 1613-1617, 2005.
20. F. Tögel, Z. Hu, K. Weiss, J. Isaac, C. Lange, and C. Westenfelder, "Administered mesenchymal stemcells protect against ischemic acute renal failure through differentiation-independentmechanisms," The American Journal of Physiology-Renal Physiology, vol. 289, no. 1, pp. F31-F42, 2005.
21. F. E. Tögel andC. Westenfelder, "Mesenchymal stem cells: a new therapeutic tool for AKI," Nature Reviews Nephrology, vol. 6, no. 3, pp. 179-183, 2010.
22. H. Pêche, M. Heslan, C. Usal, S. Amigorena, and M. C. Cuturi, "Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection," Transplantation, vol. 76, no. 10, pp. 1503-1510, 2003.
23. H. Pêche, K. Renaudin, G. Beriou, E. Merieau, S. Amigorena, and M. C. Cuturi, "Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model," American Journal of Transplantation, vol. 6, no. 7, pp. 1541-1550, 2006.
24. K. Jaquet, K. T. Krause, J. Denschel et al. , "Reductionofmyocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism?" Stem Cells and Development, vol. 14, no. 3, pp. 299-309, 2005.
25. D. Poehnert, V. Broecker,M. Mengel, B. Nashan, andM. Koch, "Induction of chronic renal allograft dysfunction in a rat model with complete and exclusive MHC incompatibility," Transplant Immunology, vol. 22, no. 3-4, pp. 137-143, 2010.
26. A. Koch, S. A. Joosten,M. Mengel,C. vanKooten,L. C. Paul, and B. Nashan, "Adoptive transfer of primed CD4+ T-lymphocytes induces pattern of chronic allograft nephropathy in a nude rat model," Transplantation, vol. 79, no. 7, pp. 753-761, 2005.
27. C. Doege, M. Koch, A. Heratizadeh, P. Sótonyi,M. Mengel, and B. Nashan, "Chronic allograft nephropathy in athymic nude rats after adoptive transfer of primed T lymphocytes," Transplant International, vol. 18, no. 8, pp. 981-991, 2005.
28. M. Z. Ratajczak, M. Kucia, T. Jadczyk et al. , "Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies," Leukemia, vol. 26, no. 6, pp. 1166-1173, 2012.
29. G. Caron, Y. Delneste, J.-P. Aubry et al. , "Human NK cells constitutively express membrane TNF- (mTNF) and present mTNF-dependent cytotoxic activity," European Journal of Immunology, vol. 29, no. 11, pp. 3588-3595, 1999.
30. T. A. Fehniger, M. H. Shah, M. J. Turner et al. , "Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response," Journal of Immunology, vol. 162, no. 8, pp. 4511-4520, 1999.
31. A. Conforti, M. Scarsella, N. Starc et al. , "Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro," Stem Cells and Development, vol. 23, no. 21, pp. 2591-2599, 2014.
32. E. Favaro, A. Carpanetto, S. Lamorte et al. , "Human mesenchymal stemcell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes," Diabetologia, vol. 57, no. 8, pp. 1664-1673, 2014.